GLIMY M V2
Rs 140.25 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
GLIMY M V2
Glimy M V2 Tablet combines Glimepiride, Metformin, and Voglibose to manage type 2 diabetes mellitus effectively. Glimepiride enhances insulin secretion from the pancreas, Metformin decreases glucose production in the liver and improves insulin sensitivity, while Voglibose slows the digestion and absorption of carbohydrates, aiding in better blood glucose control. Typically taken once daily with meals, this combination helps maintain optimal blood glucose levels. Common side effects include nausea, diarrhea, abdominal pain, and hypoglycemia. This medication is not recommended for individuals with severe kidney or liver disease, type 1 diabetes, heart failure, or for pregnant and breastfeeding women. Regular monitoring and adherence to a prescribed diet and exercise plan are essential for effective diabetes management.
Product Highlights and Usage:
Active Ingredients: Contains Glimepiride 2 mg, Metformin 500 mg, and Voglibose 0.2 mg. Benefits: Manages type 2 diabetes mellitus when diet, exercise, and single-agent or second-line therapy with two drugs are insufficient to control blood sugar. Usage: Taken orally once daily with meals, as prescribed by a physician. Mechanism: Glimepiride stimulates insulin secretion, Metformin reduces glucose production in the liver, and Voglibose slows carbohydrate digestion and absorption. Safety: Not suitable for individuals with severe kidney or liver disease, type 1 diabetes, heart failure, or during pregnancy and breastfeeding; consult a doctor before use.
How it works:
GLIMY M V2 TABLET is used to manage type 2 diabetes mellitus. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin decreases glucose production in the liver and reduces glucose absorption in the stomach and intestine. It also helps restore the body’s response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars, thereby slowing the digestion and absorption of carbohydrates in the small intestine. This combined effect helps to reduce blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take GLIMY M V2 TABLET as directed by your physician. Swallow the tablet with a glass of water and avoid crushing or chewing it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY CONTRAINDICATED: GLIMY M V2 TABLET is not recommended during pregnancy as it may harm the fetus. Consult your doctor before using it. BREASTFEEDING CONTRAINDICATED: GLIMY M V2 TABLET is not recommended for breastfeeding women, as it may pass into breast milk and potentially harm the nursing child. Consult your doctor before using it. DRIVING AND USING MACHINES USE WITH CAUTION: Avoid driving or operating machinery if GLIMY M V2 TABLET causes impaired alertness or reactions due to hypoglycemia. ALCOHOL CONSULT YOUR DOCTOR: Avoid alcohol while taking GLIMY M V2 TABLET, as it may lower your blood sugar levels. KIDNEY CONSULT YOUR DOCTOR: GLIMY M V2 TABLET is not recommended for patients with severe renal failure and should be used with caution in those with other kidney diseases. Consult your doctor before using it. LIVER CONSULT YOUR DOCTOR: GLIMY M V2 TABLET is not recommended for individuals with severe liver disease and should be used with caution in those with other liver conditions. Consult your doctor before using it. ALLERGY CONTRAINDICATED: Do not use GLIMY M V2 TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas or sulphonamides, or any other ingredients in this medicine. LUNGS CONTRAINDICATED: GLIMY M V2 TABLET is not recommended for patients with lung issues, such as acute or chronic respiratory failure. Consult your doctor before using it. HEART DISEASE CONTRAINDICATED: GLIMY M V2 TABLET is not recommended for individuals with heart problems, such as acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before using it. USE IN PEDIATRICS CONTRAINDICATED: GLIMY M V2 TABLET is not recommended for children and adolescents under 18 years of age, as its safety and effectiveness in this age group are not established. Consult your doctor before using it. USE IN GERIATRICS USE WITH CAUTION: GLIMY M V2 TABLET should be used with caution in elderly patients aged 65 years and above. Consult your doctor before using it.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$